Representative April McClain Delaney (Democratic-Maryland) recently sold shares of Labcorp Holdings Inc. (NYSE:LH). In a filing disclosed on September 09th, the Representative disclosed that they had sold between $1,001 and $15,000 in Labcorp stock on August 7th.
Representative April McClain Delaney also recently made the following trade(s):
- Sold $100,001 – $250,000 in shares of Wabtec (NYSE:WAB) on 8/25/2026.
- Sold $100,001 – $250,000 in shares of Viking (NYSE:VIK) on 8/25/2026.
- Sold $100,001 – $250,000 in shares of Trimble (NASDAQ:TRMB) on 8/25/2026.
- Sold $100,001 – $250,000 in shares of Transdigm Group (NYSE:TDG) on 8/25/2026.
- Sold $15,001 – $50,000 in shares of Tractor Supply (NASDAQ:TSCO) on 8/25/2026.
- Sold $15,001 – $50,000 in shares of Middleby (NASDAQ:MIDD) on 8/25/2026.
- Sold $15,001 – $50,000 in shares of Teledyne Technologies (NYSE:TDY) on 8/25/2026.
- Sold $100,001 – $250,000 in shares of STERIS (NYSE:STE) on 8/25/2026.
- Sold $100,001 – $250,000 in shares of Somnigroup International (NYSE:SGI) on 8/25/2026.
- Sold $100,001 – $250,000 in shares of Signet Jewelers (NYSE:SIG) on 8/25/2026.
Labcorp Price Performance
Shares of Labcorp stock traded up $4.40 during trading on Friday, reaching $311.36. The company’s stock had a trading volume of 809,927 shares, compared to its average volume of 635,612. The company has a market capitalization of $25.25 billion, a P/E ratio of 25.75, a price-to-earnings-growth ratio of 1.74 and a beta of 0.88. Labcorp Holdings Inc. has a 12-month low of $244.52 and a 12-month high of $341.80. The business has a 50 day moving average price of $310.39 and a 200-day moving average price of $281.94. The company has a quick ratio of 1.53, a current ratio of 1.80 and a debt-to-equity ratio of 0.69.
Labcorp Announces Dividend
The firm also recently declared a quarterly dividend, which was paid on Friday, September 11th. Stockholders of record on Friday, August 28th were issued a $0.72 dividend. This represents a $2.88 annualized dividend and a dividend yield of 0.9%. The ex-dividend date of this dividend was Friday, August 28th. Labcorp’s dividend payout ratio (DPR) is currently 23.82%.
Insider Buying and Selling
In other news, EVP Amy B. Summy sold 924 shares of the business’s stock in a transaction dated Tuesday, August 4th. The shares were sold at an average price of $306.74, for a total value of $283,427.76. Following the completion of the sale, the executive vice president owned 6,956 shares of the company’s stock, valued at approximately $2,133,683.44. The trade was a 11.73% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, EVP Kathryn W. Kyle sold 92 shares of the stock in a transaction dated Thursday, July 2nd. The stock was sold at an average price of $286.19, for a total transaction of $26,329.48. Following the transaction, the executive vice president directly owned 3,904 shares in the company, valued at $1,117,285.76. The trade was a 2.30% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 8,919 shares of company stock worth $2,826,593 over the last 90 days. 0.84% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Labcorp
Institutional investors and hedge funds have recently modified their holdings of the company. California State Teachers Retirement System boosted its holdings in shares of Labcorp by 28,952.8% during the second quarter. California State Teachers Retirement System now owns 35,002,800 shares of the medical research company’s stock worth $9,800,784,000 after purchasing an additional 34,882,320 shares during the last quarter. Victory Capital Management Inc. grew its position in Labcorp by 103.1% during the fourth quarter. Victory Capital Management Inc. now owns 5,356,825 shares of the medical research company’s stock valued at $1,343,922,000 after acquiring an additional 2,719,475 shares during the period. Allspring Global Investments Holdings LLC lifted its position in Labcorp by 1.0% during the first quarter. Allspring Global Investments Holdings LLC now owns 2,226,446 shares of the medical research company’s stock valued at $607,241,000 after buying an additional 22,170 shares in the last quarter. Geode Capital Management LLC raised its position in Labcorp by 0.6% in the fourth quarter. Geode Capital Management LLC now owns 2,137,010 shares of the medical research company’s stock valued at $534,023,000 after purchasing an additional 13,775 shares during the period. Finally, Wellington Management Group LLP boosted its holdings in Labcorp by 15.9% in the 3rd quarter. Wellington Management Group LLP now owns 2,105,791 shares of the medical research company’s stock worth $604,488,000 after acquiring an additional 289,029 shares during the period. Hedge funds and other institutional investors own 95.94% of the company’s stock.
Trending Headlines about Labcorp
Here are the key news stories impacting Labcorp this week:
- Positive Sentiment: Labcorp reaffirmed its 2026 guidance of adjusted EPS of $18.10 to $18.55, broadly consistent with the analyst consensus of $18.32. Maintaining guidance supports confidence in near-term earnings visibility. Labcorp Holdings Reiterates 2026 Outlook, Issues Long-Term Guidance
- Positive Sentiment: The company issued a 2029 outlook calling for compound annual revenue growth of 5% to 8% and adjusted EPS growth of 8.5% to 11.5%. The targets imply sustained expansion beyond the current year and could support a higher long-term earnings outlook. Labcorp 2026 Investor Day Announcement
- Positive Sentiment: Labcorp plans to use artificial intelligence, specialty testing, scientific capabilities and global scale to drive growth. Management also emphasized strong cash-flow generation and disciplined capital deployment, which may improve shareholder returns if execution meets expectations. Labcorp Bets Big on AI and Specialty Testing
- Neutral Sentiment: The Investor Day transcript provided additional detail on Labcorp’s strategic priorities and long-term financial framework, but the benefits depend on successful implementation and investment in new technologies and testing capabilities. Labcorp Analyst and Investor Day Transcript
- Negative Sentiment: LH recently declined about 4.3% and underperformed peers, indicating that investors may have viewed the Investor Day information as insufficient to justify the stock’s elevated valuation or may have taken profits despite the favorable long-term targets. Labcorp Stock Heads Into the Open After a 4.3 Percent Slide
Wall Street Analysts Forecast Growth
LH has been the topic of a number of research reports. Deutsche Bank Aktiengesellschaft restated a “hold” rating and issued a $306.00 price target on shares of Labcorp in a report on Friday, July 31st. Barclays raised their price target on Labcorp from $320.00 to $330.00 and gave the company an “equal weight” rating in a research report on Friday. Piper Sandler boosted their price objective on shares of Labcorp from $300.00 to $309.00 and gave the stock a “neutral” rating in a research report on Tuesday, August 4th. Morgan Stanley lifted their target price on shares of Labcorp from $308.00 to $338.00 and gave the stock an “overweight” rating in a research report on Friday, July 31st. Finally, Truist Financial upped their price target on shares of Labcorp from $320.00 to $350.00 and gave the company a “buy” rating in a report on Friday, July 31st. Nine equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat, Labcorp presently has an average rating of “Moderate Buy” and a consensus target price of $336.36.
Check Out Our Latest Stock Report on LH
About Representative McClain Delaney
April McClain-Delaney (Democratic Party) is a member of the U.S. House, representing Maryland’s 6th Congressional District. She assumed office on January 3, 2025. Her current term ends on January 3, 2027.
McClain-Delaney (Democratic Party) is running for re-election to the U.S. House to represent Maryland’s 6th Congressional District. She declared candidacy for the 2026 election.
April McClain-Delaney grew up in Buhl, Idaho, where her father was a potato farmer. She obtained her bachelor’s degree in communications from Northwestern University in 1986 and her law degree from Georgetown Law Center in 1989. McClain-Delaney worked in communications law, first with the satellite firm Orion Network Systems and later as the Washington director for Common Sense Media, a nonprofit focused on technology and children. In 2022, McClain-Delaney joined the U.S. Department of Commerce under President Joe Biden (D) as deputy assistant secretary for communications and information. McClain-Delaney served on the board of the Georgetown University Law Center, the International Center for Research on Women, and the Northwestern University School of Communications.
About Labcorp
Labcorp (NYSE: LH), formerly Laboratory Corporation of America Holdings, is a global life sciences and laboratory services company headquartered in Burlington, North Carolina. The company provides diagnostic testing and related services to physicians, hospitals, health systems, employers, government agencies and consumers.
Its diagnostics business offers routine and specialty laboratory testing, including molecular, genetic, oncology, women’s health, infectious disease and pathology services.
Read More
- Five stocks we like better than Labcorp
- Rocket Lab Tackles a Supply Chain Bottleneck as the Stock Hunts for a Bottom. Time to Buy?
- Optical Cable Corporation Is Starting to Get the Market’s Attention
- Oil Above $100 Is Creating a New Opportunity Beyond the Major Producers
- Is Nike’s Index Demotion a Warning or a Buying Opportunity?
Receive News & Ratings for Labcorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Labcorp and related companies with MarketBeat.com's FREE daily email newsletter.
